10x Genomics valuation
$56.30Change from previous close: +2.38%Absolute change: +$1.31
Valuation
The average price target of 14 analysts is $68.14.
Data as of November 15, 2026
10x Genomics compared with similar companies
10x Genomics's Price/book: 9.13, +81% against the median of a group of 11 similar companies (5.04).
| Metric | 10x Genomics | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/book | 9.13 | 5.04 | 2.90 – 7.18 | High |
| Price/sales | 12.4 | 4.05 | 3.08 – 7.03 | High |
| Gross margin | 72.0% | 68.0% | 64.3% – 70.6% | High |
| Operating margin | -10.6% | 19.2% | 15.2% – 22.0% | Low |
| Net margin | -10.8% | 13.4% | 10.0% – 14.6% | Low |
| ROE | -8.3% | 11.6% | 10.0% – 18.0% | Low |
| Debt/equity | 0.09 | 0.55 | 0.21 – 0.63 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $7.65B
- Enterprise value
- $7.15B
- P/E (trailing 12 months)
- -142.2
- Forward P/E
- 671.4
- EV/EBITDA
- -269.9
- EV/revenue
- 11.6
Profitability and growth
- ROA
- -3.9%
- ROIC
- -5.8%
- Revenue growth (year over year)
- 1.1%
- Earnings growth (year over year)
- -150.2%
Financial health
- Total cash
- $575.68M
- Total debt
- $75.79M
- Current ratio
- 5.12
- Quick ratio
- 4.52
- Altman Z-Score
- 9.25
- Piotroski F-Score
- 4.00
Dividends
- Dividend yield
- 0.0%
Analysts and estimates
- Average price target
- $68.14
- Median price target
- $65.00
- High price target
- $100.00
- Low price target
- $50.00
- Analysts with a price target
- 14
- Consensus
- Buy
- Forward EPS
- $0.09
- EPS estimate, current year
- $0.06
Shares and trading
- Beta
- 2.03
- Average volume
- 3.37M
- Shares outstanding
- 121.46M
- Float
- 119.44M
- Institutional ownership
- 115.6%
- Insider ownership
- 1.8%
- Short interest (% of float)
- 13.9%
- Short ratio (days)
- 3.13
